🇺🇸 FDA
Patent

US 6159684

HIV trans-activator TAT binding to CDK7 and activation of CTD phosphorylation

expired A61KA61K38/00A61P

Quick answer

US patent 6159684 (HIV trans-activator TAT binding to CDK7 and activation of CTD phosphorylation) held by The Regents of the University of California expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P31/18